Search

Author/Creator Mullarkey, Matthew P

3. EXTH-77. TARGETING CD73 IN GBM SENSITIZES TUMORS TO ONCOLYTIC VIRUS THERAPY. (14th November 2022)

Authors:
Murphy, Sara; Mullarkey, Matthew P; Sahu, Upasana; Hong, Bangxing; Lewis, Cole; Diaz, Miguel; Wenzel, Pamela; Kamal, Abu Hena Mostafa; Putluri, Nagireddy; Park, Junhyoung; Kaipparettu, Benny; Kaur, Balveen
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PKR induces TGF-β and limits oncolytic immune therapy. Issue 2 (16th February 2023)

Authors:
Hong, Bangxing; Sahu, Upasana; Mullarkey, Matthew P; Hong, Evan; Pei, Guangsheng; Yan, Yuanqing; Otani, Yoshihiro; Banasavadi-Siddegowda, Yeshavanth; Fan, Huihui; Zhao, Zhongming; Yu, Jianhua; Caligiuri, Michael A; Kaur, Balveen
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. TMIC-39. TARGETING EXTRACELLULAR MATRIX HYALURONIC ACID-CD44 SIGNALING REDUCES TUMOR STEMNESS AND SENSITIZES TUMOR TO VIROTHERAPY AND ENHANCES THERAPEUTIC POTENTIAL FOR CANCER TREATMENT. (14th November 2022)

Authors:
Sahu, Upasana; Mullarkey, Matthew P; Hong, Evan; Guangsheng, Pei; Zhongming, Zhao; Hong, Bangxing; Kaur, Balveen
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search